TY - JOUR
AU - Jones, Christopher M.
AU - Radhakrishna, Ganesh
AU - Aitken, Katharine
AU - Bridgewater, John
AU - Corrie, Pippa
AU - Eatock, Martin
AU - Goody, Rebecca
AU - Ghaneh, Paula
AU - Good, James
AU - Grose, Derek
AU - Holyoake, Daniel
AU - Hunt, Arabella
AU - Jamieson, Nigel B.
AU - Palmer, Daniel H.
AU - Soonawalla, Zahir
AU - Valle, Juan W.
AU - Hawkins, Maria A.
AU - Mukherjee, Somnath
PY - 2020
DA - November
TI - Reply to comment on “The UK consensus position on the treatment of pancreatic cancer during the COVID-19 pandemic”
JO - British Journal of Cancer
EP - 680
VL - 124
DO - https://doi.org/10.1038/s41416-020-01133-8
AB - We read with interest Arshad et al.’s thoughts on our guidance, which was made available to and revised in response to feedback from clinicians from the outset of the COVID-19 pandemic.We note that the authors have not commented on any specific aspect of the article’s content; instead proffering their appraisal of the authors, coupled with a call for business as usual alongside an inference that amidst an unprecedented pivot in NHS care towards patients with COVID-19 at a time when up to a fifth of medical staff were off work, such guidance was redundant.The in-excess of 2200 downloads of, and over 400 visits to, the treatment protocols and webpages respectively associated with this guidance suggest such conjecture to be erroneous, but we fully dissect their multiple assumptions in turn here.
PB - Springer Nature
UR - https://eprints.gla.ac.uk/291204/
KW - Coronavirus (COVID-19)
ER